Chest
-
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The Baseline (BDI) and Transition Dyspnea Index (TDI) are interview-based multidimensional instruments to assess breathlessness in patients with COPD. However, BDI/TDI interviewer process may introduce bias in the interpretation, leading to more variability in results. Innovative self-administered computerized (SAC) versions of the BDI/TDI were developed and validated for the BLAZE study which allows patients to provide direct ratings of breathlessness based on activities of daily living. ⋯ Anthony D'Urzo: Consultant fee, speaker bureau, advisory committee, etc.: AD has received research, consulting and lecturing fees from GlaxoSmithkline, Sepracor, Schering Plough, Altana, Methapharma, AstraZeneca, ONO pharma, Merck Canada, Forest Laboratories, Novartis Canada/USA, Boehringer Ingelheim (Canada) Ltd, Pfizer Canada, SkyePharma, and KOS Pharmaceuticals. Donald Mahler: Consultant fee, speaker bureau, advisory committee, etc.: The presenting author is a consultant for GlaxoSmithKline, Novartis, and Sunovion, and have served on Advisory Boards for Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pearl, and Sunovion, The C linical Trials Office at Dartmouth-Hitchcock Medical C enter (DHMC ) is currently receiving grants for clinical trials from Boehringer Ingelheim, Novartis, and Sunovion; Donald A. Mahler, M.D. is the DHMC principal investigator for these studies. Tracy White: Employee: Novartis employee Vijay Alagappan: Employee: Novartis employee Hungta Chen: Employee: Novartis employee Karoly Kulich: Employee: Novartis employee Nicola Gallagher: Employee: Novartis employee Donald Banerji: Employee: Novartis employee The following authors have nothing to disclose: Vanessa BrunelClinical trial results of QVA149, combination of two approved products indacaterol and glycopyrronium, will be presented, QVA 149 is in the late stage phase 3 trials prior to approval.
-
Transplantation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: We retrospectively reviewed the complications occurred in the immediate postoperatory (IPO) of lung transplantation (LTx). ⋯ Jordi Rello: Grant monies (from sources other than industry): Study financed partly with Spanish Government Grant FIS PI11/01122 The following authors have nothing to disclose: Jordi Riera, Berta Caralt, Salvador Augustin, Joan Ramon Masclans, Merce Canela, Antonio RomanNo Product/Research Disclosure Information.
-
DVT/PE PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To analyze the characteristics of patients admitted for acute pulmonary thromboembolism (PE) and identify whether there are differences in presentation, severity and outcome at discharge of elderly patients (> 75 years) comparing to the younger patients. ⋯ The following authors have nothing to disclose: Pedro Pires Goncalves, Jacinto Hernández Borge, María del Carmen García García, Hernando Chávez Roldán, José Antonio Gutierrez Lara, María José Antona Rodríguez, Amparo Sanz Cabrera, Francisca Lourdes Márquez Pérez, Pilar Cordero Montero, Ignacio Rodríguez BlancoNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 12:15 PM - 01:15 PMPURPOSE: Although plasma BNP level is considered to be a useful biomarker for identifying cardiac involvement in patients with Sarcoidosis (Sarc) few data exist for its predictive role in mortality. Our aim was to investigate the predictive role of BNP on all-cause mortality. ⋯ The following authors have nothing to disclose: Elias Gialafos, Vasileios Kouranos, Aggeliki Rapti, Efrosyni Manali, Theodore Papaioannou, Nikolaos Koulouris, Spuridon Papiris, Athol Wells, George TzelepisNo Product/Research Disclosure Information.
-
COPD Rehabilitation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Chronic obstructive pulmonary disease (COPD) impacts negatively on the quality of life of patients. Several studies have shown that acute exacerbations (AEs) decrease health-related quality of life, pulmonary function and survival of COPD patients. The objective of the present study was to examine the effects of a physical therapy program on quality of life in COPD patients hospitalized due to an acute exacerbation. ⋯ The following authors have nothing to disclose: Irene Torres-Sánchez, Marie Carmen Valenza, Gerald Valenza-Demet, Irene Cabrera-Martos, María José Flores-Barba, Angela Ruíz-SáezNo Product/Research Disclosure Information.